tirzepatide weekly dosage chart MOUNJARO® Prefilled Pen (Tirzepatide)* Inj 10mg/.5ml MOUNJARO (TIRZEPATIDE) KWIKPEN 10mg/0.6ml prefilled

Having moderate to severe diabetic retinopathy before starting the medication A history of poorly controlled blood sugar over many years High blood pressure that is not well managed Kidney disease or other diabetes-related complications Very rapid reduction in hemoglobin A1C levels within the first few months Rare cases of sudden, painless vision loss from optic nerve injury have been reported in people using GLP-1 receptor agonist medications

Verify at your Kaiser pharmacy

Ethics statement The studies involving humans were approved by All studies involving humans were approved by the Medical Ethics Committee of Hebei Provincial Peoples Hospital in 2023 (2023022)

While these drugs may work for some patients, they come with different side effects and might not be suitable for everyone

Recent studies support the long-term impairment of cognitive functionsespecially executive functionand their association with inflammatory markers (57)

The remaining authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article